Featured Research

from universities, journals, and other organizations

New Study Lays To Rest Concerns About Virtual Colonoscopy As A Screening Tool

Date:
November 4, 2004
Source:
American Roentgen Ray Society
Summary:
Virtual colonoscopy can effectively detect flat lesions in the colon, a study of more than 1,200 patients shows. The study results lay to rest concerns that virtual colonoscopy should not be used as a screening tool to detect colon cancer because it can’t detect these lesions, the study authors say.

Virtual colonoscopy can effectively detect flat lesions in the colon, a study of more than 1,200 patients shows. The study results lay to rest concerns that virtual colonoscopy should not be used as a screening tool to detect colon cancer because it can’t detect these lesions, the study authors say.

“Studies from Asia have indicated that flat lesions are quite common, and often turn into cancer,” said Perry Pickhardt, MD, associate professor of radiology at the University of Wisconsin Medical School in Madison. “Therefore it has been argued that virtual colonoscopy should not be used as a screening tool if it misses these lesions,” he said.

However this study found that virtual colonoscopy detected 80% of the flat lesions (47 of 59 lesions) that were 6mm or more in size. Virtual colonoscopy detected 81% of the non-flat lesions, Dr. Pickhardt said. Twenty-nine of the 59 flat lesions were adenomas, which are potential precursors to cancer, said Dr. Pickhardt. Virtual colonoscopy detected 83% of the flat adenomas. It detected 86% (156 of 181) non-flat adenomas, he added. “It is apparent that virtual colonoscopy is equally good for detecting both flat and non-flat types of lesions,” he said.

The study also found that flat adenomas are “uncommon in a typical western screening population, and advanced flat neoplasms are rare,” said Dr. Pickhardt. The study found no diminutive flat lesions that were histologically advanced in the 1,233 patients screened with virtual colonoscopy, he said.

The study was sponsored by the Department of Defense and was conducted at the National Naval Medical Center in Bethesda, MD, Walter Reed Army Medical Center in Washington, DC, and the Naval Medical Center in San Diego, CA. All patients underwent both a virtual colonoscopy and a standard (optical) colonoscopy. All were considered “healthy” at the time of the colonoscopy examinations.

The study was published in the November 2004 issue of the American Journal of Roentgenology.


Story Source:

The above story is based on materials provided by American Roentgen Ray Society. Note: Materials may be edited for content and length.


Cite This Page:

American Roentgen Ray Society. "New Study Lays To Rest Concerns About Virtual Colonoscopy As A Screening Tool." ScienceDaily. ScienceDaily, 4 November 2004. <www.sciencedaily.com/releases/2004/11/041104010346.htm>.
American Roentgen Ray Society. (2004, November 4). New Study Lays To Rest Concerns About Virtual Colonoscopy As A Screening Tool. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2004/11/041104010346.htm
American Roentgen Ray Society. "New Study Lays To Rest Concerns About Virtual Colonoscopy As A Screening Tool." ScienceDaily. www.sciencedaily.com/releases/2004/11/041104010346.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins